Cartilage Regeneration in Osteoarthritic Patients by a Composite of Allogeneic Umbilical Cord Blood-Derived Mesenchymal Stem Cells and Hyaluronate hydrogel: Results from a Clinical Trial for Safety and Proof-of-Concept with 7 Years of Extended Follow-Up
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, Yong-Beom | - |
dc.contributor.author | Ha, Chul-Won | - |
dc.contributor.author | Lee, Choong-Hee | - |
dc.contributor.author | Yoon, Young Cheol | - |
dc.contributor.author | Park, Yong-Geun | - |
dc.date.available | 2019-03-08T09:38:10Z | - |
dc.date.issued | 2017-02 | - |
dc.identifier.issn | 2157-6564 | - |
dc.identifier.issn | 2157-6580 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/4887 | - |
dc.description.abstract | Few methods are available to regenerate articular cartilage defects in patients with osteoarthritis. We aimed to assess the safety and efficacy of articular cartilage regeneration by a novel medicinal product composed of allogeneic human umbilical cord blood-derived mesenchymal stem cells (hUCB-MSCs). Patients with Kellgren-Lawrence grade 3 osteoarthritis and International Cartilage Repair Society (ICRS) grade 4 cartilage defects were enrolled in this clinical trial. The stem cell-based medicinal product (a composite of culture-expanded allogeneic hUCB-MSCs and hyaluronic acid hydrogel [Cartistem]) was applied to the lesion site. Safety was assessed by the World Health Organization common toxicity criteria. The primary efficacy outcome was ICRS cartilage repair assessed by arthroscopy at 12 weeks. The secondary efficacy outcome was visual analog scale (VAS) score for pain on walking. During a 7-year extended follow-up, we evaluated safety, VAS score, International Knee Documentation Committee (IKDC) subjective score, magnetic resonance imaging (MRI) findings, and histological evaluations. Seven participants were enrolled. Maturing repair tissue was observed at the 12-week arthroscopic evaluation. The VAS and IKDC scores were improved at 24 weeks. The improved clinical outcomes were stable over 7 years of follow-up. The histological findings at 1 year showed hyaline-like cartilage. MRI at 3 years showed persistence of the regenerated cartilage. Only five mild to moderate treatment-emergent adverse events were observed. There were no cases of osteogenesis or tumorigenesis over 7 years. The application of this novel stemcell-basedmedicinal product appears to be safe and effective for the regeneration of durable articular cartilage in osteoarthritic knees. | - |
dc.format.extent | 9 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | WILEY | - |
dc.title | Cartilage Regeneration in Osteoarthritic Patients by a Composite of Allogeneic Umbilical Cord Blood-Derived Mesenchymal Stem Cells and Hyaluronate hydrogel: Results from a Clinical Trial for Safety and Proof-of-Concept with 7 Years of Extended Follow-Up | - |
dc.type | Article | - |
dc.identifier.doi | 10.5966/sctm.2016-0157 | - |
dc.identifier.bibliographicCitation | STEM CELLS TRANSLATIONAL MEDICINE, v.6, no.2, pp 613 - 621 | - |
dc.description.isOpenAccess | Y | - |
dc.identifier.wosid | 000398198500024 | - |
dc.identifier.scopusid | 2-s2.0-85011381500 | - |
dc.citation.endPage | 621 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 613 | - |
dc.citation.title | STEM CELLS TRANSLATIONAL MEDICINE | - |
dc.citation.volume | 6 | - |
dc.type.docType | Article | - |
dc.publisher.location | 미국 | - |
dc.subject.keywordAuthor | Osteoarthritis | - |
dc.subject.keywordAuthor | Cartilage regeneration | - |
dc.subject.keywordAuthor | Mesenchymal stem cells | - |
dc.subject.keywordAuthor | Human umbilical cord blood | - |
dc.subject.keywordAuthor | Hyaluronic acid | - |
dc.subject.keywordPlus | BONE-MARROW | - |
dc.subject.keywordPlus | MICROFRACTURE TECHNIQUE | - |
dc.subject.keywordPlus | ADIPOSE-TISSUE | - |
dc.subject.keywordPlus | RAT MODEL | - |
dc.subject.keywordPlus | UC BLOOD | - |
dc.subject.keywordPlus | IN-VIVO | - |
dc.subject.keywordPlus | REPAIR | - |
dc.subject.keywordPlus | KNEE | - |
dc.subject.keywordPlus | TRANSPLANTATION | - |
dc.relation.journalResearchArea | Cell Biology | - |
dc.relation.journalWebOfScienceCategory | Cell & Tissue Engineering | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.